Literature DB >> 16132344

Modeling of human corticosteroid binding globulin. Use of structure-activity relations in soft steroid binding to refine the structure.

Roy J Little1, C G Rodríguez.   

Abstract

PURPOSE: We propose a model for human corticosteroid binding globulin that is capable of explaining at the molecular level the experimentally observed binding affinities of four ligands. A new method of analyzing data from docking studies is proposed.
METHODS: Displacement of radioactive ligand by competitive binding gives the experimentally determined binding affinities of the competitors. A theoretical model, based on homology with crystallographically determined structures, was studied in an automated docking procedure for the determination of theoretical affinities. The docking runs were analyzed by a hybrid principal component-clustering analysis.
RESULTS: Of the two binding sites considered, only one--that in the vicinity of Cys 60--can reproduce the experimentally observed order of binding affinities although the lowest energies are found at the site in the vicinity of Cys 228.
CONCLUSIONS: Models proposed for proteins should be always conditioned to take into account experimentally observed results. In the current work, we have shown that an informed analysis of theoretical docking studies can lead to a more logical model of the protein, one that can explain and give a deeper understanding of the stereochemical requirements of binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132344     DOI: 10.1007/s11095-005-7624-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

Review 1.  Retrometabolic drug design--novel aspects, future directions.

Authors:  N Bodor
Journal:  Pharmazie       Date:  2001-10       Impact factor: 1.267

Review 2.  Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.

Authors:  Nicholas Bodor; Peter Buchwald
Journal:  Mol Biotechnol       Date:  2004-02       Impact factor: 2.695

3.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

4.  Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors.

Authors:  G L Hammond; C L Smith; I S Goping; D A Underhill; M J Harley; J Reventos; N A Musto; G L Gunsalus; C W Bardin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  The influence of 21-acylation of corticosterone on its binding affinity for corticosteroid-binding globulin.

Authors:  R M Berko; W H Pearlman
Journal:  J Steroid Biochem       Date:  1981-10       Impact factor: 4.292

6.  Substitutions of tryptophan residues in human corticosteroid-binding globulin: impact on steroid binding and glycosylation.

Authors:  G V Avvakumov; G L Hammond
Journal:  J Steroid Biochem Mol Biol       Date:  1994-06       Impact factor: 4.292

7.  Identification of Trp-371 as the main site of specific photoaffinity labeling of corticosteroid binding globulin using delta 6 derivatives of cortisol, corticosterone, and progesterone as unsubstituted photoreagents.

Authors:  C Grenot; T Blachère; M Rolland de Ravel; E Mappus; C Y Cuilleron
Journal:  Biochemistry       Date:  1994-08-02       Impact factor: 3.162

8.  Steroid--protein interactions. Influence of steroid structure and temperature on the binding of steroids to guinea pig corticosteroid-binding globulin.

Authors:  K E Mickelson; U Westphal
Journal:  Biochemistry       Date:  1980-02-05       Impact factor: 3.162

9.  Investigation of the binding site of human corticosteroid-binding globulin by affinity labeling. Demonstration of a cysteinyl residue in the binding site.

Authors:  M S Khan; W Rosner
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

10.  Identification of the cysteine in the steroid-binding site of human corticosteroid binding globulin by site-directed mutagenesis and site-specific chemical modification.

Authors:  J Ghose-Dastidar; R Green; J B Ross
Journal:  J Steroid Biochem Mol Biol       Date:  1994-01       Impact factor: 4.292

View more
  1 in total

1.  Modeling of peroxide activation in artemisinin derivatives by serial docking.

Authors:  Roy J Little; Alexis A Pestano; Zaida Parra
Journal:  J Mol Model       Date:  2009-01-14       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.